These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 17289675)
1. Inhibition of G alpha i2 activation by G alpha i3 in CXCR3-mediated signaling. Thompson BD; Jin Y; Wu KH; Colvin RA; Luster AD; Birnbaumer L; Wu MX J Biol Chem; 2007 Mar; 282(13):9547-9555. PubMed ID: 17289675 [TBL] [Abstract][Full Text] [Related]
2. The chemokines CXCL9, CXCL10, and CXCL11 differentially stimulate G alpha i-independent signaling and actin responses in human intestinal myofibroblasts. Kouroumalis A; Nibbs RJ; Aptel H; Wright KL; Kolios G; Ward SG J Immunol; 2005 Oct; 175(8):5403-11. PubMed ID: 16210647 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist. Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110 [TBL] [Abstract][Full Text] [Related]
4. CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11). Sauty A; Colvin RA; Wagner L; Rochat S; Spertini F; Luster AD J Immunol; 2001 Dec; 167(12):7084-93. PubMed ID: 11739530 [TBL] [Abstract][Full Text] [Related]
5. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection. Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837 [TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation. Xanthou G; Williams TJ; Pease JE Eur J Immunol; 2003 Oct; 33(10):2927-36. PubMed ID: 14515277 [TBL] [Abstract][Full Text] [Related]
7. Gαi2- and Gαi3-specific regulation of voltage-dependent L-type calcium channels in cardiomyocytes. Dizayee S; Kaestner S; Kuck F; Hein P; Klein C; Piekorz RP; Meszaros J; Matthes J; Bjrnbaumer L; Nürnberg B; Herzig S PLoS One; 2011; 6(9):e24979. PubMed ID: 21966394 [TBL] [Abstract][Full Text] [Related]
8. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11. Xanthou G; Duchesnes CE; Williams TJ; Pease JE Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299 [TBL] [Abstract][Full Text] [Related]
9. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Li K; Ross DJ; Strieter RM J Immunol; 2002 Jul; 169(2):1037-49. PubMed ID: 12097412 [TBL] [Abstract][Full Text] [Related]
10. Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity. Gazi L; Nickolls SA; Strange PG Br J Pharmacol; 2003 Mar; 138(5):775-86. PubMed ID: 12642378 [TBL] [Abstract][Full Text] [Related]
11. Label-free impedance responses of endogenous and synthetic chemokine receptor CXCR3 agonists correlate with Gi-protein pathway activation. Watts AO; Scholten DJ; Heitman LH; Vischer HF; Leurs R Biochem Biophys Res Commun; 2012 Mar; 419(2):412-8. PubMed ID: 22349504 [TBL] [Abstract][Full Text] [Related]
12. Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function. Colvin RA; Campanella GS; Sun J; Luster AD J Biol Chem; 2004 Jul; 279(29):30219-27. PubMed ID: 15150261 [TBL] [Abstract][Full Text] [Related]
13. CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system. Christensen JE; de Lemos C; Moos T; Christensen JP; Thomsen AR J Immunol; 2006 Apr; 176(7):4235-43. PubMed ID: 16547260 [TBL] [Abstract][Full Text] [Related]
14. Effect of the G-protein, G alpha(i2), and G alpha(i3) subunit knockdown on bradykinin-induced signal transduction in rat-1 cells. Yang X; Taylor L; Polgar P Mol Cell Biol Res Commun; 1999 Jun; 1(3):227-36. PubMed ID: 10425231 [TBL] [Abstract][Full Text] [Related]
15. Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11. Dagan-Berger M; Feniger-Barish R; Avniel S; Wald H; Galun E; Grabovsky V; Alon R; Nagler A; Ben-Baruch A; Peled A Blood; 2006 May; 107(10):3821-31. PubMed ID: 16368892 [TBL] [Abstract][Full Text] [Related]
16. CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase. Smit MJ; Verdijk P; van der Raaij-Helmer EM; Navis M; Hensbergen PJ; Leurs R; Tensen CP Blood; 2003 Sep; 102(6):1959-65. PubMed ID: 12750173 [TBL] [Abstract][Full Text] [Related]
17. Gαi2 is the essential Gαi protein in immune complex-induced lung disease. Wiege K; Ali SR; Gewecke B; Novakovic A; Konrad FM; Pexa K; Beer-Hammer S; Reutershan J; Piekorz RP; Schmidt RE; Nürnberg B; Gessner JE J Immunol; 2013 Jan; 190(1):324-33. PubMed ID: 23225882 [TBL] [Abstract][Full Text] [Related]
18. CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis. Colvin RA; Campanella GS; Manice LA; Luster AD Mol Cell Biol; 2006 Aug; 26(15):5838-49. PubMed ID: 16847335 [TBL] [Abstract][Full Text] [Related]
19. Galpha(i2) but not Galpha(i3) is required for muscarinic inhibition of contractility and calcium currents in adult cardiomyocytes. Nagata K; Ye C; Jain M; Milstone DS; Liao R; Mortensen RM Circ Res; 2000 Nov; 87(10):903-9. PubMed ID: 11073886 [TBL] [Abstract][Full Text] [Related]
20. Defective macrophage migration in Gαi2- but not Gαi3-deficient mice. Wiege K; Le DD; Syed SN; Ali SR; Novakovic A; Beer-Hammer S; Piekorz RP; Schmidt RE; Nürnberg B; Gessner JE J Immunol; 2012 Jul; 189(2):980-7. PubMed ID: 22706085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]